Traws Pharma, Inc. (TRAW) › Net IncomeTraws Pharma, Inc. (TRAW) — Net IncomeAnnual figures by fiscal year, from SEC filings.2011: -$26.29M2012: -$29.91M2013: -$62.54M2014: -$63.68M2015: -$23.98M2016: -$19.67M2017: -$24.09M2018: -$20.57M2019: -$21.50M2020: -$25.16M2021: -$16.16M2022: -$18.96M2023: -$18.95M2024: -$166.52M2025: $9.17M$9.17M2011Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025$9.17M+105.5%2024-$166.52M-778.8%2023-$18.95M+0.1%2022-$18.96M-17.3%2021-$16.16M+35.8%2020-$25.16M-17.0%2019-$21.50M-4.5%2018-$20.57M+14.6%2017-$24.09M-22.5%2016-$19.67M+18.0%2015-$23.98M+62.3%2014-$63.68M-1.8%2013-$62.54M-109.1%2012-$29.91M-13.8%2011-$26.29M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share